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Abstract  
AIM: To evaluate cardiac affection in type 1 diabetes in relation to Omentin.  
PATIENTS AND METHODS: Sixty two diabetics and 30 volunteer of the same age and sex were 
included as a control group. Blood sample was taken for assessment of omentin and oxidized low 
density lipoprotein (OxLDL), glycosylated hemoglobin (HbA1) and lipid profile. Urine sample was 
taken for assessment of albumin/ creatinine ratio. 24 hour holter was also done. T-test, simple 
correlation followed by stepwise multiple regression analysis was used for analysis of data.  
RESULTS: Parameters of 24 hour holter were significantly lower in diabetics. Omentin was 
significantly lower, while OxLDL were significantly higher than controls. RMSSD, ST deviation and 
OxLDL were the parameters related to omentin by stepwise multiple regression analysis in 
diabetics.  
CONCLUSION: Diabetic patients had a cardiac autonomic neuropathy. A significant reduction of 
omentin and elevation OxLDL imply that they influence glucose metabolism in type 1 diabetes. 
Omentin had a significant relation to 24 hr holter which may reflect its role in cardiac affection. 
Omentin and OxLDL had a role in renal affection. 
 
 
 
 
 
Introduction 
 
Like an endocrine organ, adipose tissue 
secretes a variety of adipokines, including leptin, 
adiponectin, visfatin, TNF-a, and IL-6 [1, 2]. These 
adipokines have widespread effects on carbohydrate 
and lipid metabolism and appear to play an important 
role in the pathogenesis of insulin resistance, 
diabetes, atherosclerosis, vascular endothelial 
dysfunction, and inflammation [3–7]. Omentin is a 
novel fat depot-specific adipokine that was identified 
from a cDNA library from visceral omental adipose 
tissue by Yang et al., [8]. The omentin gene is located 
in the 1q22–q23 chromosomal region, which has been 
linked to type 2 diabetes in different populations [9–
12]. Omentin mRNA is predominantly expressed in 
the stromal vascular fraction of visceral adipose tissue 
and is barely detectable in subcutaneous fat depots 
and mature adipocytes. There are two highly 
homologous isoforms of omentin, omentin-1 and 
omentin-2; omentin-1 is the major circulating form in 
human plasma [13]. The biological activity of omentin 
is not well understood. Recombinant omentin 
enhances insulin-stimulated glucose uptake and Akt 
phosphorylation in human subcutaneous and visceral 
adipocytes in vitro, but has no effect on basal glucose 
uptake [14, 15]. 
 We are aiming to evaluate cardiac affection in 
type 1 diabetic patients in relationship to omentin.  
 
Patients and Methods 
 
Patients 
The study included 62 patients with type 1 
diabetes mellitus (DM) among those attending to the 
endocrine clinic. The control group consisted of 30 
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healthy friends and relatives of our patients of age and 
sex matched. Inclusion criteria: Patients with Duration 
of disease > 5 years and Patients age > 14 and < 19 
yrs old. Exclusion criteria were as follows: Patients 
during acute diabetic complications e.g. diabetic 
ketoacidosis (DKA) or hypoglycemia and patients 
suffering from cardiac diseases, for example, 
congenital, rheumatic heart, and left ventricular 
dysfunction and patients receiving drugs for 
cardiovascular disease. 
The study design and protocol was a cross 
sectional observational study done after obtaining 
approval from the Ethical Committee of the National 
Research Centre. The registration number was 
11052. Written informed consent was obtained from 
all patients, their parents and controls after full 
discussion about the aim of the study. The study 
conforms to the Declaration of Helsinki. This study is a 
part of a project undertaken in the National Research 
Centre for evaluation of cardiac, vascular, and 
endothelial function in adolescent type 1 diabetic 
patients. All the studied patients were subjected to 
history taking including age of patients, sex, age of 
onset of diabetes, duration of diabetes, type and dose 
of insulin therapy, and family history of diabetes. We 
asked about presence of any symptoms of cardiac, 
renal, neurological affection or presence of any type of 
autonomic dysfunction. We also asked about history 
of taking drugs other than insulin. Patients and 
controls were subjected to general, cardiac, chest, 
and neurological examination. 
Patients and controls were subjected to all 
methods: 
Blood pressure was measured three times 
after 5-minute rest in the sitting position on both upper 
limbs with the use of automatic manometer (Omron 
M4 Plus, Omron Healthcare Europe, Hoofddorp, and 
Holland). The mean value of the second and the third 
measurement was calculated. The measurements 
taken on the dominant limb were analyzed.  
Anthropometric measurements in the form of 
weight, height, waist circumference (WC), and hip 
circumference (HC) were taken for each participant. 
The weight and height of the participants were 
measured up to 0.01 kg and 0.1 cm using a Seca 
Scale Standing Balance and a Holtain Portable 
Anthropometer (Holtain, Ltd, Crymmych, Wales, U.K.). 
Body mass index (BMI) was calculated as weight (in 
kilograms) divided by height (in meters) squared. 
Waist circumference was measured at the level of the 
umbilicus with the participant standing and breathing 
normally; hip circumference was measured at the 
level of the iliac crest, using non stretchable plastic 
tape to the nearest 0.1 cm. The waist / hip ratio and 
waist/height ratio (cm/cm) were calculated. Each 
measurement was taken as the mean of three 
consecutive measurements, using standardized 
equipment [16, 17]. The landmarks, instruments used, 
and techniques followed were those recommended by 
the international biological program [16, 17]. 
All patients and controls underwent the 
following tests: For cholesterol measurements, 
venous blood was sampled after a 12-h fast. Serum 
total cholesterol was determined by a commercial kit 
(Boehringer-Mannheim, Germany) [18]. High-density 
lipoprotein (HDL) cholesterol was separated from the 
serum by precipitation of the other lipoproteins with a 
heparin/manganese procedure [19]. Low-density 
lipoprotein (LDL) cholesterol was calculated using the 
Friedewald equation. The concentration of 
triglycerides(Tg) was measured in a TechnoCon 
AutoAnalyzer II (TechnoCon Instruments, Tarrytown, 
NY, USA). Glycosylated hemoglobin (HbA1) was done 
every 3 months and the mean value was calculated 
per year. It was measured using high pressure liquid 
chromatography (Nichols Institute, Van Nuys, CA, 
USA) [20]. Screening for microalbuminuria was 
assessed in fresh morning urine samples by 
measuring albumin/creatinine ratio by enzyme linked 
immunosorbent assay (ELISA) kit provided by 
Orgentec Diagnostika, Gmbh (Mainz, Germany) [21]. 
Omentin, protein levels were measured by 
using commercially available enzyme-linked 
immunosorbent assays (ELISA) from Adlitteram 
Diagnostic Laboratories (U.S.A.) according to 
manufacturer’s protocol.  
Serum concentrations of oxidized low-density 
lipoprotein (OxLDL) were detected by a commercially 
available solid phase two-site enzyme immunoassay 
kit (Mercodia AB, Uppsala, Sweden). Measurements 
of the OxLDL levels in the sera were performed 
according to the recommendations of the 
manufacturer. The intra and interassay coefficients of 
variations were 5.5% – 7.3% and 4.0% – 6.2%, 
respectively, and the sensitivity was < 1 mU/L [22, 23]. 
Heart rate variability (HRV) was measured by 
computerized analysis of long-term heart rate samples 
(1024 beats) using 24-hour Holter monitoring space 
lab boarded in which the software automatically 
calculates all heart rate indices in a comprehensive 
and accurate form. Spectral analysis was performed 
on linearly resample (1 Hz) time series using Welch’s 
method [24]. Time domain analysis was computed on 
differing computations of the measurement of the 
standard deviation (SD) of heart period, based on 
sinus rate and rhythm (R-R) intervals over time [25, 
26]. The time domain analysis of heart rate variability 
can be further divided into two categories. One 
category is derived from the R-R intervals, using 
means and standard deviations of the intervals 
measured in milliseconds. Measures in this category 
include the SDRR. The SDRR is the standard 
deviation of all R-R intervals during a 24-h period. 
Values for SDRR that are < 50 ms have been 
associated with sudden cardiac death [27]. The 
second category of time domain variables is derived 
from differences between adjacent R-R intervals and 
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includes indices that are independent of circadian 
rhythms. The PNN50 is the proportion of the total R-R 
intervals that have differences of successive R-R 
intervals > 50 ms. SDARR is the standard deviation 
value of all averaged normal sinus R-R intervals for 
each 5-min segment in the 24-h recordings.  
The RMSSD is the square root of the mean 
squared differences of successive R-R intervals. 
Reflecting alterations in autonomic function that are 
primarily vagally mediated, the PNN50, SDRR, and 
RMSSD correlate highly with high-frequency power, 
reflecting parasympathetic modulation [25].  
Other time domain variables reflect a mixture 
of parasympathetic, sympathetic, and other 
physiologic influences [26, 28].The end of the T wave 
was defined as the point of maximal change in the 
slope as the T wave merges with the baseline. QT 
interval was corrected (QTc) for heart rate by 
calculating QTc. QTc was calculate using Bazett’ s 
equation [QTc = QT interval (ms)/ √ (60/heart rate)] 
[29]. 
 
Statistical Analysis 
Statistical analysis was conducted using 
Statistical Package for Social Science (SPSS) 
program version 15.0 (Chicago, Illinois, USA). t -test 
for independent variables was done. Mann Whitney U 
test was done for data not symmetrically distributed. 
Pearson or Spearman correlation was also done for 
omentin . Stepwise multiple regression analysis was 
also performed to find an association of omentin with 
Variables which had p value <0.05 in simple 
correlation analysis (Pearson’s or Spearman). 
 
 
Results 
 
The study included 62 patients with type 1 
diabetes (31 males and 31 females) and 30 healthy 
volunteer (15 males and 15 females). All diabetic 
patients were on intensive insulin therapy regimen. 
Comparison between demographic, anthropometric 
and laboratory data of patients and controls were 
shown in Table 1.  
Omentin was significantly lower, while OxLDL 
was significantly higher than controls (Table 1). 
SDRR, DRR, SDDRR, PNN50 and RMSSD were 
significantly lower in diabetics than controls (Fig. 1). 
No Significant difference was found between Omentin 
and sex. Also, no significant correlation was found 
between omentin and demographic, anthropometric 
data, HbA1, cholesterol, Tg, HDL and LDL.  
 
Table 1: Comparison between demographic data, 
anthropometric data and laboratory data of patients and 
controls 
Variables 
Patients Controls 
P-value Mean SD Mean SD 
Age (yrs) 16.32 1.52 16.13 2.63 0.70 
Anthropometric data: 
     BMI (kg/m
2
) 24.91 4.20 24.76 5.67 0.8 
Waist circumference (cm) 83.60 9.39 84.78 12.25 0.60 
HIP circumference (cm) 91.69 8.37 91.20 11.93 0.80 
Waist / hip ratio 0.91 0.06 0.93 0.05 0.20 
Waist / height ratio 0.51 0.06 0.52 0.08 0.90 
Blood pressure: 
     Systolic blood pressure 
(mmHg) 119.35 12.53 118.21 14.42 0.70 
Diastolic  blood pressure 
(mmHg) 81.94 9.20 78.57 6.51 0.05 
Laboratory data: 
     HBA1 (%) 9.55 1.90 5.43 0.65 0.0001 
Albumin/  creatinine ratio 
(µg/ g  creatinine) 78.33 100.65 11.28 4.23 0.0001 
Total cholesterol (mg/dl) 188.81 63.77 100.54 20.41 0.0001 
Triglyceride (mg/dl) 103.46 78.29 68.89 28.39 0.03 
HDL-c (mg/dl) 51.77 20.58 52.21 11.12 0.90 
LDL-c (mg/dl) 118.66 47.53 62.50 19.88 0.0001 
Omentin (ng/ml) 18.7 4.3 26.7 4.4 0.0001 
OxLDL (mg/L) 17.6 6.5 9.1 3.9 0.0001 
t-test  for independent  variables , Mann Whitney u test; OxLDL: Oxidized low density 
lipoprotein,  VLDL : very low density lipoprotein,  BMI: body mass index 
 
Omentin had a significant negative correlation 
with OxLDL (r = - 0.35, P = 0.01) and VLDL (r = - 0.5, 
P = 0.02) and positive correlation with RMSSD (r = 
0.3, P = 0.04), ST deviation (r = 0.37, P = 0.01). 
 
Figure 1: Comparison between parameters of 24 hr holter of 
diabetics and controls 
 
Omentin had a significant negative correlation 
(r = - 0.3, P = 0.02), while OxLDL had a significant 
positive correlation (r = 0.6, P = 0.0001) with 
albumin/creatinine ratio Table 2).  
RMSSD (β = 0.1, 95 % 0.2 -0.04, P = 0.005), 
ST deviation (β = 3.7, 95 % C.I.: 0.9 – 6.4, P= 0.01) 
and OxLDL (β = -0.2, 95 % C.I.: -0.4- 0.009, p = 0.04) 
were the parameters related to omentin by stepwise 
multiple regression analysis in diabetics (Table 3).  
 
 
Discussion 
 
In the current study, HRV in the form of 
SDRR, DRR, SDDRR, PNN50 and RMSSD were 
significantly lower in diabetics than controls. Within 
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the pediatric literature, HRV (a measure of 
cardiovascular autonomic function) was lower in 
adolescents with type 1 diabetes mellitus (T1DM) 
compared to healthy controls [26, 30, 31] and lower in 
youth with T2DM versus T1DM [32]. Chen et al., [33], 
reported that, time domain is thought to be a marker 
of parasympathetic function, and these findings 
suggest that it can be detected early before any 
manifestation of symptoms and when conventional 
tests are still normal.  
Table 2: Correlation between omentin with demographic, 
anthropometric, laboratory data and 24 hour holter of diabetic 
patients 
Variables 
Omentin 
r P-value 
Demographic data: 
  Age of patients (yrs) 0.08 0.56 
Duration of disease (yrs) -0.05 0.71 
Insulin dose (U/kg) 0.05 0.69 
Blood pressure: 
  Systolic blood pressure (mmHg) 0.04 0.74 
Diastolic blood pressure (mmHg) 0.12 0.36 
Anthropometric data: 
  BMI (SDS) -0.04 0.75 
Waist cirumference (cm) -0.02 0.86 
Hip circumference (cm) -0.03 0.81 
Waist /hip ratio 0.01 0.92 
Waist / hieght ratio -0.04 0.75 
Laboratory data: 
  HBA1 (%) 0.07 0.63 
Albumin / creatinine ratio (µg/g 
creatinine) - 0.32 0.02 
Cholesterol (mg/dl) -0.19 0.16 
Triglyceride (mg/dl) -0.03 0.83 
HDL-c (mg/dl) -0.19 0.14 
LDL-c (mg/dl) -0.12 0.36 
VLDL (mg/dl) -0.54 0.02 
OXLDL (mg/L) -0.35 0.01 
24 hour Holter: 
  SDARR (ms) 0.20 0.16 
SDRR (ms) 0.13 0.35 
DRR (ms) 0.05 0.72 
SDDRR (ms) 0.01 0.93 
PNN50 (%) 0.25 0.06 
RMSSD (ms) 0.26 0.04 
QTC -0.11 0.44 
ST  deviation 0.37 0.01 
Pearson’s or Spearman correlation. OxLDL: Oxidized low density lipoprotein,  VLDL: very 
low density lipoprotein,  BMI: body mass index, SDRR is the standard deviation of all R-R 
intervals during a 24-h period, PNN50 is the proportion of the total R-R intervals that have 
differences of successive R-R intervals > 50 ms, SDARR is the standard deviation value of 
all averaged normal sinus R-R intervals for each 5-min segment in the 24-h recordings, 
The RMSSD is the square root of the mean squared differences of successive R-R 
intervals. Bold font indicates significant. 
 
 
It also suggests that parasympathetic 
autonomic dysfunction is the first abnormality to arise 
in the development of cardiac autonomic neuropathy 
(CAN) [34]. Time domain analysis of HRV, has 
several advantages over conventional techniques. In 
addition to being a more sensitive measure of 
autonomic dysfunction, it is easy to perform with 
limited specialist training, does not require expensive 
and cumbersome equipment, is very quick to carry 
out, and is not affected by subject variability [34]. 
 In the present study, diastolic blood pressure, 
HbA1, albumin/creatinine ratio, cholesterol, 
triglyceride, LDL and OxLDL were significantly higher, 
while omentin was significantly lower in diabetics than 
controls. 
It has been recognized that T1DM is a 
proinflammatory state and in obese subjects with 
T1DM, insulin resistance can accelerate progression 
of T1DM complications [35, 36]. Recently, Tan et al., 
[37], reported decreased circulating omentin and 
increased adiponectin levels in subjects with T1DM. 
Circulating omentin levels and omental adipose tissue 
(AT) omentin mRNA expression were found to be 
significantly lower in impaired glucose tolerant (IGT), 
T2DM subjects and overweight insulin-resistant 
women with PCOS compared with matched controls 
[37-40]. 
Table 3: Stepwise multiple regression analysis of omentin with 
24 hr holter, VLDL, albumin / creatinine ratio and oxidized LDL 
(OxLDl) 
Variables B 95% 
Confidence interval 
P-value 
Constant 27.8 21.7 – 33.8 0.0001 
RMSSD (ms) 0.1 0.2 – 0.04 0.005 
ST deviation 3.7 0.9 – 6.4 0.01 
OxLDl (mg/L) -0.2 -0.4 - -0.009 0.04 
R
2
 = 0.5, SEM = 3.43; R
2
: Coefficient of determination, SEM= standard error of mean; 
Dependent variables: omentin; Independent variables: VLDL, albumin/creatinine ratio, 
OxLDL, RMSSD and ST deviation; The RMSSD is the square root of the mean squared 
differences of successive R-R intervals, OxLDL: Oxidized low density lipoprotein 
 
Epicardial adipokines, may play an important 
role in the pathogenesis of coronary vascular disease. 
In particular, coronary atherosclerosis, given that 
there is no fibrous fascial layer to hinder diffusion of 
free fatty acid (FFAs) and adipokines between 
epicardial AT and the underlying vessel wall as well 
as the myocardium [37, 41].  
 In our study, no significant difference was 
found between Omentin and sex. Also there was no 
significant correlation between omentin and 
demographic, anthropometric data, HbA1, cholesterol, 
triglyceride (Tg), HDL and LDL. In the contrary, Pan et 
al., [15] and Tan et al., [42], reported that omentin-1 
level was lower in female subjects with type 1 
diabetes. De Souza Batista et al., [13], reported that, 
circulating omentin levels were negatively correlated 
with markers of obesity (body mass index, waist 
circumference, and circulating leptin).  
In the current study, omentin had a significant 
negative correlation with OxLDL (r = - 0.35, P = 0.01), 
VLDL (r = - 0.5, P = 0.02), albumin/creatinine ratio (r = 
- 0.3, P = 0.02) and positive correlation with RMSSD (r 
= 0.3, P = 0.04) and ST deviation (r = 0.37, P = 0.01). 
RMSSD (β = 0.1, 95 % C.I.: 0.2 - 0.04, P = 0.005), ST 
deviation (β = 3.7, 95 % C.I. : 0.9 – 6.4, P 0.01) and 
OxLDL (β = -0.2, 95 % C.I.: -0.4- 0.009, p = 0.04) 
were the parameters related to omentin by stepwise 
multiple regression analysis in diabetics. This means 
that omentin can be used for early detection of cardiac 
autonomic dysfunction (microvascular complication) 
before symptoms of CAN and it is decreased with 
increase in the oxidative stress. Omentin may play a 
protective role not only in coronary atherosclerosis but 
also in other obesity-related cardiovascular disorders, 
specifically, hypertension, given the vasodilating effect 
of omentin on blood vessels [35]. 
Tan et al., [38], found that omentin decreased 
human sera–induced Akt activation in human 
endothelial cells. Thus, omentin may play an 
important role in the relationship between 
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inflammation, angiogenesis, and the pathogenesis of 
atherosclerosis [43]. Omentin is lower in patients with 
coronary artery disease [44]. 
  Limitation of the study: Number of patients is 
small, 24 hour Holter takes a long time and needs to 
convince the patients to use it, Omentin is a new 
adipocytokines and very minimal lectures are present.  
 In conclusion, diabetic patients have reduced 
HRV. Omentin is lower in diabetic patients and this 
could help for the utilization as a prospective bio 
marker for cardiac pathology. This novel 
adipocytokine may be important future targets for the 
development of drugs and therapy for treating 
metabolic vascular disorders. Genetic study of 
omentin polymorphism is essential. 
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